Cardiff Oncology, Inc.
CRDF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $11 | $24 | $51 |
| Short-Term Investments | $50 | $60 | $56 | $40 |
| Receivables | $0 | $1 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $2 | $3 |
| Total Curr. Assets | $62 | $74 | $83 | $95 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $64 | $76 | $85 | $97 |
| Liabilities | – | – | – | – |
| Payables | $2 | $6 | $4 | $5 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $10 | $9 | $8 |
| Total Curr. Liab. | $15 | $17 | $13 | $13 |
| LT Debt | $0 | $0 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $2 |
| Total Liabilities | $15 | $17 | $14 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$423 | -$412 | -$398 | -$384 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $472 | $470 | $468 | $467 |
| Total Equity | $49 | $59 | $71 | $83 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $64 | $76 | $85 | $97 |
| Net Debt | -$9 | -$10 | -$23 | -$50 |